Navigation Links
Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
Date:5/17/2010

successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the risks that: the FDA's requirement that Soligenix conduct additional clinical trials to demonstrate the safety and efficacy of orBec® will take a significant amount of time and money to complete and positive results leading to regulatory approval cannot be assumed; Soligenix is dependent on the expertise, effort, priorities and contractual obligations of third parties in the clinical trials, manufacturing, marketing, sales and distribution of its products; orBec® may not gain market acceptance if it is eventually approved by the FDA; and others may develop technologies or products superior to orBec®. Factors affecting the development and use of SGX201 and LPM™ are similar to those affecting orBec®. These and other factors are described from time to time in filings with the Securities and Exchange Commission, including, but not limited to, Soligenix's reports on Forms 10-Q and 10-K. Unless required by law, Soligenix assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.


'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
3. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
4. Soligenix Reports Third Quarter 2009 Financial Results
5. Soligenix to Present at 8th Annual BIO Investor Forum
6. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
7. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
8. Sinovac Reports Unaudited First Quarter 2010 Financial Results
9. Microbix Reports a Record Increase in Worldwide Sales for 2nd Quarter 2010
10. Transdel Pharmaceuticals Reports First Quarter 2010 Results
11. Aeterna Zentaris Reports First Quarter 2010 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from clinical ... key industry events beginning with Patient-Centered Clinical Trials 2014 ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits ... variety of tactics – from media to mobile apps – ...
(Date:8/28/2014)... 2014 Sterlitech is proud to announce ... its stable of products . These additional ... and include membrane filters with surface charges. ... demand for our membrane process testing equipment, and correspondingly, ... sheet membranes,” explains Sterlitech President Mark Spatz. “The ...
(Date:8/28/2014)... Exciting new work by a Florida State University research ... can take your temperature, emit white light, and convert ... molecule looks like a butterfly. , Biwu Ma, associate ... in the FAMU-FSU College of Engineering, created the molecule ... continued to discover that his creation has many other ...
(Date:8/28/2014)... Woodstock, Vt. (PRWEB) August 28, 2014 ... microbiology testing around the world is available from ... industrial diagnostics companies. “ Industrial Microbiology Market Review, ... the Industrial Market ” (IMMR—4) tracks and compares ... in in North America, Europe and Asia, and ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Sterlitech Corporation Enhances Its Selection of Flat Sheet Membrane Filters 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... Beckman Coulter,s Worldwide Position in Clinical Chemistry- ... Chemistry and Automation Broaden Global Opportunity, Increase ... of Beckman Coulter,s Immunoassay Products into Olympus, ... Transaction Expected to be Accretive to Non-GAAP ...
... Martin (NYSE: LMT ) has partnered with ... energy sector. As part of the corporation,s commitment to tackling ... research and development projects at Penn State in ... Lockheed Martin - Penn State collaboration will focus ...
... Pressure BioSciences, Inc. (Nasdaq: PBIO ) ... EdgeWater Research Partners, Micro/Small-Cap Investor Conference to be held ... on Wednesday, March 4, 2009. Mr. Richard T. ... PBI Chairman, will give a corporate overview at 10:35 ...
Cached Biology Technology:Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 2Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 3Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 4Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 5Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 6Lockheed Martin Invests in Smart Grid Research and Development at Penn State University 2Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners' Spring 2009 Micro/Small-Cap Investor Conference 2
(Date:8/31/2014)... discovered that ,good, cholesterol is turned ,bad, by a ... was found to damage ,good, HDL cholesterol, which removes ... , Low levels of HDL, High Density Lipoprotein, are ... MG being common in the elderly and those with ... from the British Heart Foundation (BHF) and published in ...
(Date:8/31/2014)... from the last 19 years reveals that fresh water from ... Antarctica to rise by 2cm more than the global average ... the rapid rise in sea-level by studying satellite scans of ... , The melting of the Antarctic ice sheet ... excess of around 350 gigatonnes of freshwater to the surrounding ...
(Date:8/29/2014)... at the Barshop Institute for Longevity and Aging Studies, ... Health Science Center at San Antonio, have found another ... rodent, the naked mole rat. , They reported ... rats protects and alters the activity of the proteasome, ... The factor also protects proteasome function in human, mouse ...
Breaking Biology News(10 mins):Sugar substance 'kills' good HDL cholesterol, new research finds 2Factor in naked mole rat's cells enhances protein integrity 2
... are substantially more different genetically than humans living on ... PLoS Genetics . The study suggests that genomics ... chimpanzee conservation, with the potential to identify the population ... of a sample of bush meat. Common ...
... shapes and sizes. Scientists have discovered simple rules that control leaf ... computer model able to accurately emulate leaf growth from a bud. ... same rate," said lead author Samantha Fox from the John Innes ... like a bud, not flat with a pointed tip." By ...
... the peas please! How often do we hear our children ... Prevention,s Youth Risk Behavior Surveillance System survey of adolescents, only 21% ... vegetables per day. So not very many children are asking ... other methods to get their children to eat their vegetables. ...
Cached Biology News:Nearby chimpanzee populations show much greater genetic diversity than distant human populations 2Nearby chimpanzee populations show much greater genetic diversity than distant human populations 3First model of how buds grow into leaves 2Should we play hide-and-go-seek with our children's vegetables? 2Should we play hide-and-go-seek with our children's vegetables? 3
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
Anti-ADAM-12 (Meltrin Alpha); carboxy terminal end; rabbit host...
Chaps Cell Extract Buffer can be used to lyse cells under nondenaturing conditions and is recommendedfor the preparation of cell lysates to be used with our caspase signaling pathway antibodies...
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications)....
Biology Products: